Biological effects of transforming growth factors

  • H. L. Moses
  • J. Keski-Oja
  • R. M. Lyons
  • N. J. Sipes
  • C. C. Bascom
  • R. J. CoffeyJr.

Abstract

Transforming growth factors (TGFs) were originally defined by their biological effects on fibroblastic cells (for review see Goustin et al. 1986). These effects included induction of morphological transformation in monolayer culture and Stimulation of colony formation in soft agar. While the early studies with TGFα were somewhat misleading with respect to the function of these factors, they did lead to the purification and cloning of two important growth-regulatory molecules, TGFα and TGFβ. Interestingly, one of these factors (TGFα) is a potent mitogen for a wide variety of cell types, while the other (TGFβ) is the most potent growth-inhibitory Polypeptide known for most cell types (Goustin et al. 1986).

Keywords

Migration Agar Tyrosine Sarcoma Polypeptide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anzano MA, Roberts AB, Smith JM, Sporn MB, DeLarco JE (1983) Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type-alpha and type-beta transforming growth factors. Proc Natl Acad Sci USA 80: 6264–6268PubMedCrossRefGoogle Scholar
  2. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258:7155–7160PubMedGoogle Scholar
  3. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, Chow EP, Fisher A, Bertonis JM, Torres G, Wallner BP, Ramachandran KL, Ragin RC, Managanaro TF, MacLaughlin DT, Donahoe PK (1986) Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cells 45: 685–698CrossRefGoogle Scholar
  4. Cheifetz S, Weatherbee JA, Tsang ML-S, Anderson JK, Mole JE, Lucas R, Massague J (1987) The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cells 48: 409–415CrossRefGoogle Scholar
  5. Childs CB, Proper JA, Tucker RF, Moses HL (1982) Serum contains platelet-derived transforming growth factor. Proc Natl Acad Sci USA 79: 5312–5316PubMedCrossRefGoogle Scholar
  6. Coffey RJ, Derynck R, Wilcox JN, Bringman TS, Goustin S, Moses HL, Pittelkow MR (1987) Production and auto-induction of transforming growth factor-beta in human keratinocytes. Nature 328:817–820PubMedCrossRefGoogle Scholar
  7. Coughlin JP, Donahoe PK, Budzik GP, MacLaughlin DT (1987) Müllerian inhibiting substance blocks autophosphorylation of the EGF receptor by inhibiting tyrosine kinase. Mol Cell Endocrinol 49: 75–86PubMedCrossRefGoogle Scholar
  8. DeLarco JE, Todaro GJ (1978) Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75: 4001–4005CrossRefGoogle Scholar
  9. Derynck R (1986) Transforming growth factor-alpha: structure and biological activities. J Cell Biochem 32: 293–304PubMedCrossRefGoogle Scholar
  10. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV (1985) Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316:701–705PubMedCrossRefGoogle Scholar
  11. Derynck R, Jarrett JA, Chen EY, Goeddel DV (1986) The murine transforming growth factor-beta precursor. J Biol Chem 261:4377–4379PubMedGoogle Scholar
  12. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty JP, Angel P, Heath JK (1987) Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6: 1899–1904PubMedGoogle Scholar
  13. Fernandez-Pol JA, Talked VD, Klos DJ, Hamilton PD (1987) Suppression of the EGF-dependent induction of c-mycproto-oncogene expression by transforming growth factor-beta in a human breast carcinoma cell line. Biochem Biophys Res Commun 144:1197–1205PubMedCrossRefGoogle Scholar
  14. Frolik CA, Wakefield LM, Smith DM, Sporn MB (1984) Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J Biol Chem 259:10995–11000PubMedGoogle Scholar
  15. Gentry LE, Webb NR, Lim GJ, Brunner AM, Ranchalis JE, Twardzik DR, Lioubin MN, Marquardt H, Purchio AF (1987) Type-1 transforming growth factor-beta: amplified expression and secretion of mature and precursor Polypeptides in Chinese hamster ovary cells. Mol Cell Biol 7: 4318–4327Google Scholar
  16. Goustin AS, Leof EB, Shipley GD, Moses HL (1986) Perspective in cancer research: growth factors and cancer. Cancer Res 46:1015–1029PubMedGoogle Scholar
  17. Holley RW, Armour R, Baldwin JH (1978) Density-dependent regulation of growth of BSC-1 cells in cell culture: growth inhibitors formed by the cells. Proc Natl Acad Sci USA 75: 1864–1866PubMedCrossRefGoogle Scholar
  18. Ignotz RA, Massague J (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337–4345PubMedGoogle Scholar
  19. Ignotz RA, Endo R, Massague J (1987) Regulation of fibronectin and type-I collagen mRNA levels by transforming growth factor-beta. J Biol Chem 262:6443–6446PubMedGoogle Scholar
  20. Keski-Oja J, Lyons RM, Moses HL (1987) Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta. Cancer Res 47: 6451–6458PubMedGoogle Scholar
  21. Laiho M, Saksela O, Andreasen PA, Keski-Oja J (1986) Enhanced production and extracellular deposition of the endothelial-type Plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 103:2403–2410PubMedCrossRefGoogle Scholar
  22. Lawrence DA, Pircher R, Kryceve-Martinerie C, Jullien P (1984) Normal embryo fibroblasts release trasforming growth factors in a latent form. J Cell Physiol 121: 184–188PubMedCrossRefGoogle Scholar
  23. Leof EB, Proper JA, Goustin AS, Shipley GD, DiCorleto E, Moses HL (1986) Induction of c-sismRNA and activity similar to platelet-derived growth factor by transforming growth factor-beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci USA 83:2453–2457PubMedCrossRefGoogle Scholar
  24. Like B, Massague J (1986) The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors. J Biol Chem 261:13426–13429PubMedGoogle Scholar
  25. Marquardt H, Hunkapiller MW, Hood LE, Todaro GJ (1984) Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science 223:1079–1082PubMedCrossRefGoogle Scholar
  26. Mason AJ, Hayflick JS, Ling N, Esch F, Ueno N, Ying Y, Guillemin R, Niall H, Seeburg PH (1985) Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature 318:659–663PubMedCrossRefGoogle Scholar
  27. Massague J (1985) Subunit structure of a high-affinity receptor for type-beta transforming growth factor. Evidence for a disulfide-linked glycosylated receptor complex. J Biol Chem 260: 7059–7066PubMedGoogle Scholar
  28. Massague J (1987) The TGF-beta family of growth and differentiation factors. Cell 49:437–438PubMedCrossRefGoogle Scholar
  29. Massague J, Like B (1985) Cellular receptors for type-beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem 260: 2636–2645PubMedGoogle Scholar
  30. Masui T, Wakefield LM, Lechner JF, La Veck MA, Sporn B, Harris CC (1986) Type-beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci USA 83: 2438–2442PubMedCrossRefGoogle Scholar
  31. Matrisian LM, Leroy P, Ruhlmann C, Gesnel M-C, Breathnach R (1986) Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol Cell Biol 6: 1679–1686PubMedGoogle Scholar
  32. Moses HL, Leof EB (1986) Transforming growth factor-beta. In: Kahn P, Graf T (eds) Oncogene and Growth Control. Springer, Berlin, Heidelberg, New York, pp. 51–57CrossRefGoogle Scholar
  33. Moses HL, Branum EB, Proper JA, Robinson RA (1981) Transforming growth factor production by chemically transformed cells. Cancer Res 41: 2842–2848PubMedGoogle Scholar
  34. Moses HL, Tucker RF, Leof EB, Coffey RJJ, Halper J, Shipley GD (1985) Type-beta transforming growth factor is a growth stimulator and a growth inhibitor. In: Feramisco J, Ozanne B, Stiles C (eds) Growth Factors and Transformation. Cancer Cells, vol 3. Cold Spring Harbor Press, Cold Spring Harbor, pp 65–71Google Scholar
  35. Padgett RW, St Johnston RD, Gelbart WM (1987) A transcript from a Drosophila-patterngene predicts a protein homologous to the transforming growth factor-beta family. Nature 325:81–84PubMedCrossRefGoogle Scholar
  36. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH (1987) Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor-beta. J Exp Med 165: 251–256PubMedCrossRefGoogle Scholar
  37. Raghow R, Postlethwaite AE, Keski-Oja J, Moses HL, Kang H (1987) Transforming growth factor-beta increases steady-state levels of type-I procollagen and fibronectin mRNA posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest 79:1285–1288PubMedCrossRefGoogle Scholar
  38. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB (1981) New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissue. Proc Natl Acad Sci USA 78: 5339–5343PubMedCrossRefGoogle Scholar
  39. Roberts AB, Frolik CA, Anzano MA, Sporn MB (1983) Transforming growth factors from neoplastic and non-neoplastic tissues. Fed Proc 42: 2621–2626PubMedGoogle Scholar
  40. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl H, Fauci AS (1986) Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivoand stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167–4171PubMedCrossRefGoogle Scholar
  41. Shipley GD, Pittelkow MR, Wille JJJ, Scott RE, Moses L (1986) Reversible inhibition of normal human prokeratinocyte proliferation by type-beta transforming growth factor-growth inhibitor in serum-free medium. Cancer Res 46: 2068–2071PubMedGoogle Scholar
  42. Sporn MB, Todaro GJ (1980) Autocrine secretion and malignant transformation of cells. N Engl JMed 303:878–880CrossRefGoogle Scholar
  43. Takehara K, LeRoy EC, Grotendorst GR (1987) TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 49: 415–422PubMedCrossRefGoogle Scholar
  44. Todaro GJ, Fryling C, DeLarco JE (1980) Transforming growth factors produced by certain human tumor cells: Polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77: 5258–5262PubMedCrossRefGoogle Scholar
  45. Tucker RF, Branum EL, Shipley GD, Ryan RJ, Moses HL (1984a) Specific binding to cultured cells of 125I-labeled transforming growth factor type-beta from human platelets. Proc Natl Acad Sci USA 81: 6757–6761PubMedCrossRefGoogle Scholar
  46. Tucker RF, Shipley GD, Moses HL, Holley RW (1984b) Growth inhibitor from BSC-1 cells closely related to the platelet type-beta transforming growth factor. Science 226: 705–707PubMedCrossRefGoogle Scholar
  47. Twardzik DR, Ranchalis JE, Todaro GJ (1982) Mouse embryonic transforming growth factors related to those isolated from tumor cells. Cancer Res 42: 590–593PubMedGoogle Scholar
  48. Wrann M, Bodmer S, de Martin R, Siepl C, Hofer-Warbinek R, Frei K, Hofer E, Fontana A (1987) T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta. EMBO J 6: 1633–1636PubMedGoogle Scholar
  49. Ying S-Y, Becker A, Ling N, Ueno N, Guillemin R (1986) Inhibin and beta-type transforming growth factor (TGF-beta) have opposite modulating effects on the follicle-stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells. Biochem Biophys Res Commun 136:969–975PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • H. L. Moses
    • 1
  • J. Keski-Oja
    • 2
  • R. M. Lyons
    • 1
  • N. J. Sipes
    • 1
  • C. C. Bascom
    • 1
  • R. J. CoffeyJr.
    • 1
  1. 1.Department of Cell BiologyVanderbilt University School of MedicineNashvilleUSA
  2. 2.Department of VirologyUniversity of HelsinkiHelsinkiFinland

Personalised recommendations